Barry Wershil, MD
Basic profileBarry Wershil is a Gastroenterology physician affiliated with Lurie Children's Hospital. OpenAlex indexes 139 publications with 9,366 citations (h-index 38); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Pediatric Gastroenterology profiles in the FindMyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20251 payment$114
- QOL Medical, LLCProgram year20251 payment$26
- AstraZeneca Pharmaceuticals LPProgram year20241 payment$2,148
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Proton pump inhibitor100%Omeprazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
Clinical Gastroenterology and Hepatology
2022 - Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms After Dilation in Adults With Eosinophilic Esophagitis
Clinical Gastroenterology and Hepatology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Lauren Pachman, MD
Lurie Children's Hospital
Riccardo Superina, MD
Lurie Children's Hospital
Earl Cheng, MD
Lurie Children's Hospital
Hector Melin Aldana, MD
Lurie Children's Hospital
Charles Rice, MD
The Rockefeller University
Jean-Frederic Colombel, MD
Icahn School of Medicine at Mount Sinai
Edward Loftus, MD
Mayo Clinic Rochester
Kris Kowdley, MD
Washington State University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”